Background: The majority of oocytes in the mammalian ovary are dormant oocytes that are enclosed in primordial follicles by several somatic cells, which we refer to as primordial follicle granulosa cells (pfGCs). Very little is known, however, about how the pfGCs control the activation of primordial follicles and the developmental fates of dormant oocytes. Results: By targeting molecules in pfGCs with several mutant mouse models, we demonstrate that the somatic pfGCs initiate the activation of primordial follicles and govern the quiescence or awakening of dormant oocytes. Inhibition of mTORC1 signaling in pfGCs prevents the differentiation of pfGCs into granulosa cells, and this arrests the dormant oocytes in their quiescent states, leading to oocyte death. Overactivation of mTORC1 signaling in pfGCs accelerates the differentiation of pfGCs into granulosa cells and causes premature activation of all dormant oocytes and primordial follicles. We further show that pfGCs trigger the awakening of dormant oocytes through KIT ligand (KITL), and we present an essential communication network between the somatic cells and germ cells that is based on signaling between the mTORC1-KITL cascade in pfGCs and KIT-PI3K signaling in oocytes. Conclusions: Our findings provide a relatively complete picture of how mammalian primordial follicles are activated. The microenvironment surrounding primordial follicles can activate mTORC1-KITL signaling in pfGCs, and these cells trigger the awakening of dormant oocytes and complete the process of follicular activation. Such communication between the microenvironment, somatic cells, and germ cells is essential to maintaining the proper reproductive lifespan in mammals.
Introduction
The development and differentiation of female germ cells require a unique microenvironment created by surrounding somatic cells. In Caenorhabditis elegans, both the self-renewal of germline stem cells (GSCs) and the differentiation of GSCs into meiosis-competent oocytes rely heavily on the involvement of the somatic cell niche found at the distal tip of the germline tissue [1, 2] . In Drosophila, the somatic cell niche in the ovary supports the self-renewal of the GSCs and is essential to maintaining germ cell production throughout adult life [2, 3] .
In mammalian ovaries, the majority of oocytes exist as small, dormant oocytes that are meiotically arrested and are enclosed in primordial follicles by several flattened somatic cells [4, 5] , which we refer to here as primordial follicle granulosa cells (pfGCs) ( Figure 1A ). In order to ensure the proper length of the organism's reproductive lifespan, most of the oocytes are maintained in a quiescent state. In humans, for example, dormant oocytes can remain in a developmentally quiescent state for as long as 50 years. However, the functions of surrounding somatic pfGCs in regulating follicular activation and the developmental fates of dormant oocytes are unclear.
To generate mature eggs in the mammalian ovary, only a limited number of dormant oocytes are progressively activated into the growing pool. During follicular activation, the dormant oocytes are awakened into a phase of rapid growth with hundreds-fold increases in volume along with massive amounts of mRNA transcription and protein translation [6] . Pioneering studies have reported that the awakening process in mammalian oocytes is associated with morphological changes of the surrounding somatic pfGCs-the flattened pfGCs first proliferate and differentiate into cuboidal granulosa cells, and this is followed by the dramatic growth of the oocytes [5, 7] . Conventional knockout of Forkhead box L2 (Foxl2), which is an important gene for the differentiation of follicle somatic cells, leads to a mild global activation of the follicular pool [8, 9] . These results indicate a functional role of the pfGCs in regulating the fates of dormant oocytes in the mammalian ovary. However, due to limitations of research tools-such as the lack of a suitable promoter that specifically targets pfGCs in vivo-whether and how the somatic pfGCs might regulate the activation of primordial follicles and contribute to the awakening of dormant oocytes in the mammalian ovary are unknown. mTORC1 (mechanistic target of rapamycin complex 1) is a conserved serine/threonine kinase that regulates cell growth and metabolism in response to growth factors and nutrients. It functions by modulating processes such as protein synthesis, ribosome biogenesis, and autophagy [10] . mTORC1 is composed of several components, including RPTOR, which is the regulatory-associated protein of mTOR. In cells, mTORC1 signaling is negatively regulated by the tumor suppressor tuberous sclerosis complex 1 (TSC1) [11] . However, the functional role of mTORC1 signaling in pfGCs is unclear.
In the current study, we have targeted the somatic pfGCs by using a pfGC-specific, tamoxifen-inducible Foxl2-CreER T2 mouse model [12] . Our results show that in mammals, pfGCs initiate the activation of primordial follicles and govern the quiescence or awakening of dormant oocytes. More specifically, by combining several mutant mouse models, we have shown that mTORC1 signaling in pfGCs plays a central role in regulating the differentiation of pfGCs into granulosa cells and in guiding the development of dormant oocytes through mTORC1-mediated expression of KIT ligand (KITL) in pfGCs. Binding of KITL to KIT on the surface of the oocytes activates the phosphatidylinositol 3-kinase (PI3K) signaling cascade in dormant oocytes and the subsequent awakening of the *Correspondence: kui.liu@gu.se dormant oocytes. This interaction between the somatic cells and germ cells in the mouse ovary serves as the initial molecular event that triggers the progressive activation of dormant oocytes into fertilizable eggs.
Results

Deletion of Rptor Specifically in PfGCs Suppresses mTORC1 Signaling in PfGCs
To determine how the somatic pfGCs might regulate follicular activation and the quiescence and awakening of dormant oocytes, we deleted Rptor (regulatory-associated protein of MTOR, complex 1)-the key component of the mTORC1 pathway-in pfGCs by crossing Rptor loxP/loxP mice with a knockin mouse line expressing tamoxifen-inducible Foxl2 promoter-mediated CreER T2 fusion protein (Foxl2-CreER T2 mice) ( Figure 1B ) [12] . The resulting mice are referred to as pfGCRptor 2/2 mice (indicating pfGC-specific knockout of Rptor) and were validated as described below.
We first crossed the Foxl2-CreER T2 mice with an mTmG reporter mouse line in which Cre recombinase-targeted cells exhibit a switch from red fluorescence (membrane-targeted Tomato; mT) to green fluorescence (membrane-targeted GFP; mG) [13] . In mice, the Foxl2 promoter becomes active during the perinatal period, when the ovarian supporting cells differentiate into pfGCs and start to form primordial follicles, and Foxl2 is expressed in both pfGCs and granulosa cells [14] . We showed that tamoxifen administration to postnatal day (PD)1 and PD4 Foxl2-CreER
T2
;mTmG pups (20 mg$kg 21 body weight) can successfully target pfGCs with high efficiency and specificity ( Figure S1A available online, pfGCs with green fluorescence) [12] . As a negative control, no green fluorescent cells were seen in mTmG mice injected with tamoxifen ( Figure S1B ). Western blot analysis showed a satisfactory reduction of RPTOR expression in the ovarian lysates of PD13 pfGC-Rptor 2/2 mice ( Figure 1C , RPTOR), and this led to impaired mTORC1 signaling as shown by reduced phosphorylation of RPS6KB1 and EIF4EBP1 ( Figure 1C , p-RPS6KB1 T389 and p-EIF4EBP1 S65).
Deletion of Rptor in PfGCs Prevents the Awakening of Dormant Oocytes and Suppresses Follicular Activation
To delete Rptor from pfGCs, tamoxifen was administered at PD1 and PD4. At PD5, the ovaries from pfGC-Rptor 2/2 mice and pfGC-Rptor +/+ control mice had similar morphologies, with mostly primordial follicles ( Figures 1D and 1E , arrowheads) and some follicles that were likely to have been activated before the tamoxifen-induced Cre recombinase became (F-I) At PD13, the pfGC-Rptor 2/2 ovaries (G and I) are smaller than the pfGC-Rptor +/+ ovaries (F and H). Numerous primordial follicles (G and I, arrowheads) but only a few growing follicles (G, arrows) were observed in the pfGC-Rptor 2/2 ovary. The experiments were repeated at least three times, and representative images are shown. See also Figure S1 .
active ( Figures 1D and 1E , arrows) [12] . This indicated that the postnatal deletion of Rptor in Foxl2-positive cells does not affect the formation of primordial follicles. At PD13, however, the pfGC-Rptor 2/2 ovaries were much smaller ( Figure 1G ) compared to the pfGC-Rptor +/+ ovaries, in which numerous activated follicles were seen ( Figures 1F  and 1H, arrows) . Most of the oocytes in the mutant ovaries remained in a quiescent state in primordial follicles ( Figures 1G  and 1I, arrowheads) . Only a few follicles were activated in the pfGC-Rptor -/-ovaries ( Figure 1G , arrows), and this most likely occurred before the complete deletion of Rptor in pfGCs. At sexual maturity (PD35), in comparison to the normal follicular development in pfGC-Rptor +/+ ovaries ( Figure S1C , arrow), the pfGC-Rptor 2/2 ovaries remained smaller ( Figure S1D , inset) because they still contained large numbers of dormant oocytes in primordial follicles ( Figure S1D, arrowheads) . Quantification of follicles in pfGC-Rptor +/+ and pfGC-Rptor
ovaries at PD5, PD13, and PD35 confirmed the suppressed follicular activation in pfGC-Rptor 2/2 ovaries ( Figure S1G ). These dormant oocytes that are arrested in the quiescent state in mutant ovaries eventually die out at around 4 months of age, and no healthy oocytes or follicles were observed in the pfGC-Rptor 2/2 ovaries ( Figure S1F ). This is in sharp contrast to the normal follicular development in pfGC-Rptor +/+ ovaries ( Figure S1E , arrows). It is thus not surprising that the pfGCRptor 2/2 females were infertile. Our results show that the deletion of Rptor in pfGCs suppresses follicular activation and prevents the awakening of dormant oocytes.
Deletion of Tsc1 in PfGCs Leads to the Global Awakening of Dormant Oocytes and the Activation of All Primordial Follicles TSC1 is an inhibitor of mTORC1 signaling [15] . To confirm that the mTORC1 signaling in pfGCs controls the quiescence or awakening of dormant oocytes, we specifically deleted the Tsc1 gene from pfGCs by crossing the Tsc1 loxP/loxP mice with Foxl2-CreER T2 mice ( Figure 2A ). The resulting mice are referred to as pfGC-Tsc1 2/2 mice. Western blot analysis showed that the reduction of TSC1 expression ( Figure 2B , TSC1) resulted in enhanced activation of mTORC1 signaling in pfGC-Tsc1 2/2 ovaries, as illustrated by the elevated level of phosphorylated RPS6KB1 ( Figure 2B , p-RPS6KB1 T389).
Tamoxifen was administered to pfGC-Tsc1 2/2 mice at PD1 and PD4. No apparent morphological difference in oocyte development was observed at PD10 between pfGC-Tsc1 Figure 2C ) and pfGC-Tsc1 2/2 ( Figure 2D ) ovaries. At PD23, however, the pfGC-Tsc1 2/2 ovaries ( Figure 2F ) were much larger than the pfGC-Tsc1 +/+ ovaries ( Figure 2E ). This was caused by the premature awakening of all dormant oocytes and activation of all primordial follicles in pfGC-Tsc1 pfGC-Tsc1 2/2 ovaries ( Figure 2H , arrowheads). This is in sharp contrast to the pfGC-Tsc1 +/+ ovaries that contained many dormant oocytes in primordial follicles ( Figure 2G , arrowheads). As expected, at PD35, the pfGC-Tsc1 2/2 ovaries (Figure S2D) were still larger than the pfGC-Tsc1 +/+ ovaries ( Figure S2C ) due to higher numbers of developing follicles containing growing oocytes and a lack of dormant oocytes in primordial follicles in the pfGC-Tsc1 2/2 ovaries ( Figure S2D , inset). In comparison, primordial follicles were observed in pfGC-Tsc1 +/+ ovaries ( Figure S2C , inset, arrows). Quantification of follicles in pfGC-Tsc1 +/+ and pfGC-Tsc1 2/2 ovaries at PD8, PD23, and PD35 confirmed the premature global follicular activation in pfGC-Tsc1 2/2 ovaries ( Figure S2G ). The prematurely activated follicles in pfGC-Tsc1 2/2 ovaries degenerated by 4 months of age ( Figure S2F , inset, arrowheads), which is in sharp contrast to the normal follicular development in pfGC-Tsc1 +/+ ovaries at 4 months ( Figure S2E ). These results showed that elevated mTORC1 signaling in the pfGCs caused premature differentiation and proliferation of pfGCs into granulosa cells and the awakening of all dormant oocytes in primordial follicles.
Our previous studies have shown that intraoocyte PI3K signaling plays a key role in controlling the growth of oocytes during the activation of primordial follicles in mice [16] . Therefore, we tested whether the overactivation of dormant oocytes in pfGC-Tsc1 2/2 ovaries was caused by a pfGC-initiated elevation of intraoocyte PI3K signaling. We performed immunofluorescence staining of FOXO3 (forkhead box O3), a downstream effector of PI3K-Akt, in the ovaries of pfGCTsc1 2/2 mice. FOXO3 shuttles from the nucleus to the cytoplasm of mouse oocytes when PI3K signaling is activated in the oocytes [17] . We observed a clear cytoplasmic localization of FOXO3 in pfGC-Tsc1 2/2 oocytes ( Figure 2J ), indicating constitutively active PI3K signaling in the oocytes of pfGCTsc1 2/2 ovaries. This is in sharp contrast to the nuclear localization of FOXO3 in the oocytes of primordial follicles in pfGC-Tsc1 +/+ females ( Figure 2I ). Therefore, our results show that the pfGC-initiated awakening of dormant oocytes in pfGC-Tsc1 2/2 ovaries occurs via activation of the oocyte PI3K pathway, which is in agreement with previous reports that the activation of intraoocyte PI3K signaling is needed for the activation of primordial follicles [16, 18] . mice were harvested and cultured in vitro for 4 days. Over the 4-day in vitro culture period, in comparison to the normal primordial follicle distribution in pfGC-Tsc1 +/+ ovaries (Figure S3A) , pfGC-Tsc1 2/2 ovaries also showed premature awakening of dormant oocytes (Figure 3A , arrows; Figure S3B ). We then cultured PD10 pfGC-Tsc1 2/2 ovaries for 4 days with inhibitors of different signaling pathways that are important for the awakening of oocytes, including rapamycin (an mTORC1 inhibitor), LY294002 (a PI3K inhibitor), genistein (a general protein tyrosine kinase inhibitor), and several inhibitors of receptor protein tyrosine kinases, including ISCK03 (a KIT inhibitor), GTP-14564 (a platelet-derived growth factor receptor inhibitor), and AGL 2263 (an insulin receptor and insulin-like growth factor [IGF] receptor inhibitor) [19] .
As expected, we found that the mTORC1 inhibitor rapamycin (10 mM) ( Figure 3B, arrowheads) , the PI3K inhibitor LY294002 (10 mM) ( Figure S3C, arrowheads) , and the general protein tyrosine kinase inhibitor genistein (50 mM) ( Figure S3D , arrowheads) suppressed the premature awakening of dormant oocytes in cultured pfGC-Tsc1 2/2 ovaries. Notably, the KIT inhibitor ISCK03 (5 mM) suppressed oocyte awakening in cultured pfGC-Tsc1 2/2 ovaries ( Figure 3C, arrowheads) , but inhibitors for other receptor protein tyrosine kinases did not suppress the premature awakening of dormant oocytes in pfGC-Tsc1 2/2 ovaries (Figures S3E-S3G ). These results suggest that the signaling between KITL in pfGCs and KIT signaling in oocytes mediates the premature awakening of dormant oocytes in pfGC-Tsc1 2/2 ovaries. Indeed, we found that at PD13 (a stage at which no apparent premature awakening of dormant oocytes had yet occurred in pfGC-Tsc1 2/2 ovaries but the pfGC differentiation into granulosa cells had started) ( Figures S2A and S2B) , the Kitl mRNA level in pfGC-Tsc1 2/2 ovaries was 2.3-fold higher than that in pfGC-Tsc1 +/+ ovaries ( Figure 3D ). This result indicates that active mTORC1 signaling enhances the expression of KITL in pfGCs.
PfGCs Awaken Dormant Oocytes through Phosphorylation of KIT Y719 and Subsequent Activation of PI3K Signaling in the Oocytes
To further determine how the KITL-KIT signaling and the intraoocyte PI3K pathway function to awaken dormant oocytes in pfGC-Tsc1 2/2 ovaries, we blocked the KIT-mediated activation of oocyte PI3K in pfGC-Tsc1 2/2 mice by crossing pfGCTsc1 2/2 mice with Kit Y719F /Kit Y719F mice that carry a point mutation in which KIT Y719 is substituted by a phenylalanine (F) [20] . The phosphorylation of KIT Y719 upon KITL binding is responsible for activating the downstream PI3K [20] , and the Y719F mutation in the pfGC-Tsc1 2/2 ;Kit Y719F /Kit Y719F mice should prevent the KIT-mediated activation of PI3K in their oocytes. We first validated the inhibition of PI3K activation in the oocytes of Kit Y719F /Kit Y719F mice. FOXO3, a downstream effector of PI3K-Akt, was localized in the nuclei of oocytes ( Figure S4A, upper inset, arrows) , and this demonstrated suppressed PI3K signaling [17] in the oocytes of the Kit Y719F /Kit Y719F mice. Not surprisingly, the development of oocytes and follicles was greatly retarded in Kit Y719F / Kit Y719F ovaries ( Figure S4 ). However, compared to the pfGCs in pfGC-Rptor 2/2 ovaries ( Figures 1G and 1I )-which are arrested in an undifferentiated stage with flattened shapes-the pfGCs in Kit Y719F /Kit Y719F ovaries can differentiate into cuboidal granulosa cells ( Figure S4C, inset, arrows) . This shows that there is no defect in the differentiation of pfGCs in Kit Y719F /Kit Y719F mice. After tamoxifen administration at PD1 and PD4, we found no apparent morphological difference between the ovaries of pfGC-Tsc1 2/2 ;Kit Y719F /Kit Y719F mice ( Figure 4A ) and those of pfGC-Tsc1 2/2 mice ( Figure 4B ) at PD4. At PD23, however, the ovaries from pfGC-Tsc1
2/2
;Kit Y719F /Kit Y719F mice (Figure 4C) were much smaller than those of pfGC-Tsc1 2/2 mice ( Figure 4D ). This was due to the large numbers of dormant oocytes in the double mutant pfGC-Tsc1 2/2 ;Kit Y719F /Kit Y719F ovaries ( Figure 4E, arrows) . It was apparent that the premature awakening of dormant oocytes seen in PD23 pfGC-Tsc1 Figure 4E , arrowheads). However, the inability to activate PI3K signaling in oocytes due to the KIT Y719F mutation prevented the dormant oocytes from being awakened ( Figure 4E, arrows) . Indeed, in PD23 pfGC-Tsc1
;Kit Y719F /Kit Y719F ovaries, the average diameter of the oocytes in activated follicles was 16.4 6 1.2 mm. This was in sharp contrast to the enlarged oocytes in the prematurely activated follicles (53.2 6 5.1 mm) in PD23 ovaries of pfGC-Tsc1 2/2 mice (Figure 4F , arrows; Figure 4G ). Moreover, a comparable level of Kitl mRNA expression was found in pfGC-Tsc1 2/2 ovaries and pfGC-Tsc1 ;Kit Y719F /Kit Y719F ovaries was indeed caused by the inability to activate oocyte PI3K signaling, we studied FOXO3 localization as an indicator of PI3K activation. There was a clear cytoplasmic localization of FOXO3 in most pfGCTsc1 2/2 oocytes at PD23 ( Figure 4J ), indicating activated PI3K signaling in the oocytes of pfGC-Tsc1 2/2 ovaries. In contrast, in pfGC-Tsc1
;KitY Y719F /Kit Y719F ovaries, FOXO3 was mainly detected in the nuclei of the oocytes ( Figure 4I ), indicating suppressed PI3K signaling. Therefore, the suppressed oocyte awakening in pfGC-Tsc1
;KitY Y719F / Kit Y719F ovaries was caused by the failure to activate PI3K signaling in the oocytes.
The above results showed that the KIT Y719-mediated PI3K activation is the sole mechanism responsible for the initiation of oocyte awakening in pfGC-Tsc1 2/2 ovaries. Even though the differentiation and proliferation of pfGCs into cuboidal granulosa cells occurred normally in pfGC-Tsc1
;KitY 719F / Kit Y719F ovaries ( Figure 4E, arrowheads) , the KIT Y719F mutation prevented activation of PI3K signaling in oocytes and the dormant oocytes could not be awakened ( Figure 4E, arrows) .
Based on these results, we conclude that mTORC1 signaling in pfGCs plays an indispensable role in initiating the activation of primordial follicles and the awakening of dormant oocytes. As summarized in Figure 5 , this is achieved first through mTORC1 activation in pfGCs that mediates the differentiation and proliferation of pfGCs into granulosa cells as well as the expression of KITL. Binding of KITL to KIT results in the phosphorylation of KIT Y719 and subsequent activation of oocyte PI3K signaling. The PI3K signaling in the oocytes is then responsible for triggering the events that awaken the oocyte from its quiescent state, as proposed earlier [16, 18] . We propose that this specific gateway through phosphorylation of KIT Y719 makes for an easily regulated system for limiting the number of primordial follicles that are activated at any given time in the mouse ovary.
Discussion
In this study, we have shown that pfGCs-the somatic components of the primordial follicle-play a fundamental role in initiating the activation of primordial follicles and governing the quiescent or awakening states of dormant oocytes in the mammalian ovary. We have described a complete set of molecular networks that mediate the interaction between somatic cells and germ cells in controlling the development of dormant mammalian oocytes ( Figure 5) . The model we present in this work has two key steps. The first is the initial up-and downregulation of mTORC1 signaling in pfGCs that acts as the key decision-making process with regard to whether or not a primordial follicle will be activated. The second step Left: if the mTORC1 signaling in pfGCs is suppressed, no or low levels of KITL are expressed by pfGCs, and this is insufficient to activate KIT on oocytes. In this situation, KIT Y719 is not phosphorylated and the intraoocyte PI3K signaling is suppressed, and this maintains the dormant oocytes in their quiescent state. Right: in a primordial follicle that is selected for activation, elevated mTORC1 signaling in the pfGCs leads to enhanced production of KITL that binds to KIT and subsequently activates the intraoocyte PI3K signaling through phosphorylation of KIT Y719. Activated PI3K signaling in oocytes awakens the dormant oocytes. Y719-P, phosphorylated KIT Y719.
involves the tightly regulated communication channel from the somatic cells to the germ cells via KITL-KIT Y719 to trigger the awakening of the oocyte. We propose that these processes ensure the progressive activation of a limited number of primordial follicles throughout the reproductive lifespan. Thus, it is likely that follicular activation is initiated by molecular and cellular changes in the somatic pfGCs that are followed by awakening of the dormant oocytes. We and others have previously shown that activated PI3K signaling in oocytes is essential for follicular activation in mouse ovaries [16, 18] . In the present study, we have expanded upon this and shown that the PI3K signaling in dormant mouse oocytes is downstream of the mTORC1-KITL cascade in pfGCs and the KIT Y719 signaling in oocytes. Thus, we can now draw a relatively complete picture of how the entire follicular activation process is initiated and of the molecular cascades involved in this process.
Our previous studies have shown that overactivation of mTORC1 signaling in the oocytes of primordial follicles leads to a global activation of the follicular pool [21, 22] . However, our unpublished data showed that the inhibition of mTORC1 signaling in oocytes by deletion of Rptor has no effect on follicular development and female fertility, and this shows that mTORC1 signaling in dormant oocytes is not essential for physiological follicular activation. Therefore, the mTORC1 signaling appears to only be essential in the pfGCs for controlling the activation of primordial follicles under physiological conditions, and more studies are needed to determine the downstream events through which mTOR signaling regulates KITL production in pfGCs and granulosa cells.
In mammals, only a limited number of primordial follicles are selectively activated, and most of the dormant follicles remain arrested in a quiescent state. This allows for an extended female reproductive lifespan. The upstream regulators of mTORC1 signaling include nutrition, oxygen, energy, and growth factors [10] . Our current study reveals that the mTORC1 signaling in pfGCs, which is potentially directly regulated by the local microenvironment, including factors transported by surrounding blood vessels, plays a primary role in controlling the developmental fates of single primordial follicles. Therefore, we hypothesize that the individual microenvironment and microcirculation surrounding each primordial follicle decide the activation of selected primordial follicles at any given time during the female's reproductive life.
In recent years, there has been an increasing trend to use in vitro activation and maturation of dormant oocytes in primordial follicles to obtain fertilizable human oocytes [23] . A healthy baby has recently been born from a primordial follicle of a woman with premature ovarian failure that was activated in vitro by enhancing PI3K signaling with PTEN (phosphatase and tensin homolog deleted on chromosome 10) inhibitors [24] . We thus propose that to achieve optimal activation of human primordial follicles during in vitro culture, it is necessary to first treat them with an mTORC1 activator to trigger the differentiation and proliferation of the pfGCs and the awakening of the oocytes. This can be followed by treatment with PTEN inhibitors to enhance the growth of the oocytes.
In summary, we have presented a complete network in the pfGCs that initiates the activation of primordial follicles and controls the development of dormant oocytes in the mammalian ovary. The results presented here will open new avenues to a better understanding of ovarian physiology and pathology.
Experimental Procedures
Mice Rptor loxP/loxP mice (013188), Tsc1 loxP/loxP mice (005680), and mTmG mice (007576) were purchased from the Jackson Laboratory. The Kit Y719F mice were kindly provided by Peter Besmer of the Memorial Sloan Kettering Cancer Center. After backcrossing to a C57BL/6J genomic background, the mice were crossed with knockin mice carrying a CreER T2 transgene mediated by the Foxl2 promoter (Foxl2-CreER T2 mice), which were also in a C57BL/6J genomic background, as we reported earlier [12] . mice, littermates that do not carry the mutation were used as control mice. The mice were housed under controlled environmental conditions with free access to water and food. Illumination was on between 0600 and 1800. Experimental protocols were approved by the regional ethical committee of the University of Gothenburg.
Reagents and Immunological Detection Methods
Tamoxifen and corn oil were purchased from Sigma-Aldrich. The rabbit polyclonal antibodies to phospho-EIF4EBP1 (S65) and phospho-RPS6KB1 (T389) and rabbit monoclonal antibodies to EIF4EBP1, RPS6KB1, and FOXO3 were obtained from Cell Signaling Technologies. Mouse monoclonal antibodies to b-actin, polyethylene glycol 400, and Tween 80 were purchased from Sigma-Aldrich. The western blots were carried out according to the instructions of the suppliers of the different antibodies and visualized using the ECL Plus Western Blotting Detection System (Amersham Biosciences). Paraffin and hematoxylin were purchased from Histolab.
The PI3K inhibitor LY294002, the mTORC1 inhibitor rapamycin, and the general protein tyrosine kinase inhibitor genistein were obtained from LC Laboratories. The KIT inhibitor ISCK03 was obtained from Sigma-Aldrich. The insulin receptor and IGF receptor inhibitor AGL 2263 and the plateletderived growth factor receptor inhibitor GTP-14564 were purchased from Calbiochem.
Tamoxifen Administration for Specifically Targeting PfGCs in Foxl2-CreER T2 Mice Tamoxifen was resuspended at 100 mg$ml 21 in 95% ethanol and further diluted with corn oil to a final concentration of 20 mg$ml 21 . To specifically target the pfGCs in primordial follicles, tamoxifen was given to neonatal female pups at PD1 and PD4 (20 mg$kg 21 body weight) by intraperitoneal injection. Based on previous reports, the recruitment of Foxl2-positive pfGCs is finished around PD5 and the primordial follicle pool is established at the same time [12] . This makes our approach ideal for deleting genes in the pfGCs of primordial follicles.
Histological Analysis and Immunofluorescence Staining
To observe the ovarian morphology, ovaries were fixed in 4% paraformaldehyde, dehydrated, and embedded in paraffin. The paraffin-embedded ovaries were serially cut into 8 mm sections and rehydrated. For morphological analysis, the sections were stained with hematoxylin and imaged with a Zeiss Axio Scope A1 upright microscope. The fluorescent images of Foxl2-CreER
T2
;mTmG ovarian sections were taken with the Zeiss Axio Scope A1 upright microscope installed with filter sets for mT (tdTomato, 554/ 581 nm) and mG (EGFP, 488/507 nm) and merged with Zeiss AxioVision software.
To detect the activation of PI3K signaling in oocytes by FOXO3 immunofluorescence staining, the sections were treated with 0.01% sodium citrate buffer (pH 6.0) for antigen retrieval. After blocking by 1.5% goat serum in PBS, the sections were incubated with FOXO3 primary antibodies overnight at 4 C and Alexa Fluor 488-conjugated secondary antibodies (Cell Signaling) at 37 C for 1 hr. The sections were then stained with 4 0 ,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich) for 5 min. The fluorescent images were taken with a Zeiss Axio Scope A1 upright microscope.
For oocyte diameter measurement, the ovaries were serially cut into 8 mm sections and rehydrated and the sections were stained with hematoxylin and imaged with a Zeiss Axio Scope A1 upright microscope. The diameters of the oocytes were measured with Zeiss AxioVision software. In each group, the average diameter was calculated from measurements of 100 random oocytes in the sections.
For quantification of ovarian follicles, ovaries were fixed in 4% paraformaldehyde, dehydrated, and embedded in paraffin. Paraffin-embedded ovaries were serially cut into 8 mm sections and stained with hematoxylin for morphological observation. The numbers of primordial follicles and activated follicles were counted in all sections of an ovary.
In Vitro Culture of Mouse Ovaries Paired ovaries from PD10 pfGC-Tsc1 2/2 female mice were collected and washed three times in DMEM/Ham's F12 medium (Invitrogen). Ovaries were cultured on Millicell inserts (Millipore) in 24-well plates (Nunc) with 500 ml of culture medium. The culture medium consisted of DMEM/Ham's F12 supplemented with 3 mg$ml 21 BSA (Sigma), 13 Insulin-TransferrinSelenium (Invitrogen), 50 U$ml 21 penicillin (Invitrogen), 50 mg$ml 21 streptomycin (Invitrogen), and 2 mM L-glutamine (Invitrogen). Ovaries were cultured for 4 days with or without the inhibitors at 37 C in a humidified atmosphere of 5% CO 2 .
Gene Expression Analysis
For the gene expression measurements in the mouse materials, total RNA was isolated from ovaries of eight mice per group with the RNeasy Mini Kit (QIAGEN) according to the manufacturer's instructions. First-strand cDNA was synthesized with the iScript cDNA Synthesis Kit (QIAGEN). Synthesized cDNA was subjected to real-time PCR for measuring Kitl with the primer pairs 5 0 -TCAACTATGTCGCCGGGATG-3 0 and 5 0 -CGAAATGAGAG CCGGCAATG-3 0 on an ABI 7500 Real-Time PCR System using SYBR Green PCR Master Mix (Applied Biosystems). The reactions were carried out in triplicate. Threshold cycle (Ct) values were obtained, and the DDCt method was used to calculate the fold changes. All of the values were normalized to levels of Gapdh.
Statistical Analysis
All experiments were repeated at least three times. Quantitative data (means 6 SEM) were analyzed by one-way ANOVA using SigmaPlot software (Systat Software).
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